Sandbox:kalpana: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
Historical Perspective
Historical Perspective


'''Diagnosis'''
==Diagnosis==
The diagnosis of fetal hydantoin syndrome is based on the dymorphic features which indcludes the spectrum of abnormalities seen in the neonate includes microcephaly, distinctive facial and limb anomalies, ocular defects, growth deficiency, congenital heart defects, cardiac rhythm disturbances, and variable systemic abnormalities involving the nervous, renal, and gastrointestinal systems. Congenital heart diseases associated with fetal hydantoin syndrome include pulmonary or aortic valvular stenosis, coarctation of aorta, patent ductus arteriosus, and ventricular septal defects.<ref name="pmid28578158">{{cite journal| author=Hegde A, Kaur A, Sood A, Dhanorkar M, Varma HT, Singh G | display-authors=etal| title=Fetal Hydantoin Syndrome. | journal=J Pediatr | year= 2017 | volume= 188 | issue=  | pages= 304 | pmid=28578158 | doi=10.1016/j.jpeds.2017.05.018 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28578158  }} </ref>
===Diagnostic Study of Choice===
The diagnosis of fetal hydantoin syndrome is based on secondary to in utero phenytoin exposure.
 
===History and Symptoms===
The diagnosis of fetal hydantoin syndrome is based on the dysmorphic features which include the spectrum of abnormalities seen in the neonate includes microcephaly, distinctive facial and limb anomalies, ocular defects, growth deficiency, congenital heart defects, cardiac rhythm disturbances, and variable systemic abnormalities involving the nervous, renal, and gastrointestinal systems. Congenital heart diseases associated with fetal hydantoin syndrome include pulmonary or aortic valvular stenosis, coarctation of aorta, patent ductus arteriosus, and ventricular septal defects.<ref name="pmid28578158">{{cite journal| author=Hegde A, Kaur A, Sood A, Dhanorkar M, Varma HT, Singh G | display-authors=etal| title=Fetal Hydantoin Syndrome. | journal=J Pediatr | year= 2017 | volume= 188 | issue=  | pages= 304 | pmid=28578158 | doi=10.1016/j.jpeds.2017.05.018 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28578158  }} </ref>

Revision as of 08:10, 9 May 2021

Historical Perspective

Diagnosis

Diagnostic Study of Choice

The diagnosis of fetal hydantoin syndrome is based on secondary to in utero phenytoin exposure.

History and Symptoms

The diagnosis of fetal hydantoin syndrome is based on the dysmorphic features which include the spectrum of abnormalities seen in the neonate includes microcephaly, distinctive facial and limb anomalies, ocular defects, growth deficiency, congenital heart defects, cardiac rhythm disturbances, and variable systemic abnormalities involving the nervous, renal, and gastrointestinal systems. Congenital heart diseases associated with fetal hydantoin syndrome include pulmonary or aortic valvular stenosis, coarctation of aorta, patent ductus arteriosus, and ventricular septal defects.[1]

  1. Hegde A, Kaur A, Sood A, Dhanorkar M, Varma HT, Singh G; et al. (2017). "Fetal Hydantoin Syndrome". J Pediatr. 188: 304. doi:10.1016/j.jpeds.2017.05.018. PMID 28578158.